Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study

被引:75
作者
Banks, E
Reeves, G
Beral, V
Bull, D
Crossley, B
Simmonds, M
Hilton, E
Bailey, S
Barrett, N
Briers, P
English, R
Jackson, A
Kutt, E
Lavelle, J
Rockall, L
Wallis, MG
Wilson, M
Patnick, J
机构
[1] Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Oxford OX2 6HE, England
[2] Princess Wales Community Hosp, Breast Screening Serv, Bromsgrove B61 0BB, Worcs, England
[3] Charing Cross Hosp, W London Breast Screening Serv, London W6 8RF, England
[4] Gloucestershire Breast Screening Serv, Cheltenham GL53 7AS, Glos, England
[5] Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Breast Care Unit, Oxford OX3 7JH, England
[6] Queen Alexandra Hosp, Patricia Massey Breast Screening Unit, Portsmouth PO6 3LY, Hants, England
[7] Cent Hlth Clin, Avon Breast Screening, Bristol BS2 0JD, Avon, England
[8] Royal Lancaster Infirm, N Lancashire Breast Screening Serv, Lancaster LA1 4GG, England
[9] Worthing Dist Hosp, W Sussex Breast Screening Serv, Worthing BN11 2DH, W Sussex, England
[10] Coventry & Warwick Hosp, Breast Screening Unit, Coventry CV1 4FH, W Midlands, England
[11] Withington Hosp, Greater Manchester Breast Screening Serv, Nightingale Ctr, Manchester M20 0PT, Lancs, England
[12] NHS Breast Screening Programme, Sheffield S11 9PS, S Yorkshire, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7464期
关键词
D O I
10.1136/bmj.329.7464.477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography. Methods Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 12355 women aged 50-64 years were followed for outcome of screening and incident breast cancer in the next 12 months. Sensitivity and specificity were calculated by using standard definitions, with adjustment for potential confounding factors. Results Breast cancer was diagnosed in 726 (0.6%) women, 629 in screen positive and 97 in screen negative women; 3885 (3.2%) were screen positive but had no subsequent diagnosis of breast cancer. Overall sensitivity was 86.6% and specificity was 96.8%. Three factors had an adverse effect on both measures: use of hormone replacement therapy (sensitivity: 83.0% (95% confidence interval 77.4% to 87.6%), 84.7% (73.9% to 91.6%), and 92.1% (87.6% to 95.0%); specificity: 96.8% (96.6% to 97.0%), 97.8% (97.5% to 98.0%), and 98.1% (98.0% to 98.2%), respectively, for current, past, and never use); previous breast surgery v no previous breast surgery (sensitivity: 83.5% (75.7% to 89.1%) v 89.4% (86.5% to 91.8%); specificity: 96.2% (95.8% to 96.5%) v 97.4% (97.3% to 97.5%), respectively); and body mass index <25 v >= 25 (sensitivity: 85.7% (81.2% to 89.3%) v 91.0% (87.5% to 93.6%); specificity: 97.2% (97.0% to 97.3%) v 97.4% (97.3% to 97.6%), respectively). Neither sensitivity nor specificity varied significantly according to age, family history of breast cancer, parity, past oral contraceptive use, tubal ligation, physical activity, smoking, or alcohol consumption. Conclusions The efficiency, and possibly the effectiveness, of mammographic screening is lower in users of hormone replacement therapy, in women with previous breast surgery, and in thin women compared with other women.
引用
收藏
页码:477 / 479
页数:5
相关论文
共 23 条
[1]  
Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319
[2]  
[Anonymous], 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16
[3]   Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the million women study [J].
Banks, E ;
Reeves, G ;
Beral, V ;
Bull, D ;
Crossley, B ;
Simmonds, M ;
Hilton, E ;
Bailey, S ;
Barren, N ;
Briers, P ;
English, R ;
Jackson, A ;
Kutt, E ;
Lavelle, J ;
Rockall, L ;
Wallis, MG ;
Wilson, M ;
Patnick, J .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7451) :1291-1292
[4]   Predictors of outcome of mammography in the National Health Service Breast Screening Programme [J].
Banks, E ;
Reeves, G ;
Beral, V ;
Bull, D ;
Crossley, B ;
Simmonds, M ;
Hilton, E ;
Bailey, S ;
Barrett, N ;
Briers, P ;
English, R ;
Jackson, A ;
Kutt, E ;
Lavelle, J ;
Rockall, L ;
Wallis, MG ;
Wilson, M .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (02) :74-82
[5]  
Banks E, 2001, J Epidemiol Biostat, V6, P357
[6]   Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review [J].
Banks, E .
JOURNAL OF MEDICAL SCREENING, 2001, 8 (01) :29-35
[7]  
BERAL V, IN PRESS MENOPAUSE H
[8]  
Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2
[9]  
Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
[10]   Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial [J].
Chlebowski, RT ;
Hendrix, SL ;
Langer, RD ;
Stefanick, ML ;
Gass, M ;
Lane, D ;
Rodabough, RJ ;
Gilligan, MA ;
Cyr, MG ;
Thomson, CA ;
Khandekar, J ;
Petrovitch, H ;
McTiernan, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24) :3243-3253